Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Data on zidovudine pharmacokinetics in children dosed using World Health Organization weight bands are limited. About 45 HIV-infected, Ugandan children, 3.4 (2.6-6.2) years, had intensive pharmacokinetic sampling. Geometric mean zidovudine AUC0-12h was 3.0, which is higher than previously observed in adults, and was independently higher in those receiving higher doses, younger and underweight children. Higher exposure was also marginally associated with lower hemoglobin.

Original publication




Journal article


Pediatr Infect Dis J

Publication Date





495 - 498


Anti-HIV Agents, Area Under Curve, Body Weight, Child, Child, Preschool, Cross-Over Studies, Female, Guidelines as Topic, HIV Infections, Hemoglobins, Humans, Infant, Male, Plasma, Uganda, World Health Organization, Zidovudine